# Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy

> **NCT00328874** · PHASE2 · COMPLETED · sponsor: **German Parkinson Study Group (GPS)** · enrollment: 20 (actual)

## Conditions studied

- Progressive Supranuclear Palsy

## Interventions

- **DRUG:** Coenzyme Q10

## Key facts

- **NCT ID:** NCT00328874
- **Lead sponsor:** German Parkinson Study Group (GPS)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-01-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00328874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00328874, "Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00328874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*